Compare Deutsche Bank AG (DB) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Medtronic PLC — how do they compare? Deutsche Bank AG trades at $33.68 (market cap $62.42B), while Medtronic PLC trades at $88.48 (market cap $112.24B). The key difference: Medtronic PLC is the larger of the two by market cap, and Deutsche Bank AG pays the higher dividend (3.46%). Which is the better fit depends on your goals — on Pluang, investors hold Deutsche Bank AG for 80 Days and Medtronic PLC for 63 Days on average.
| DB | MDT | |
|---|---|---|
Market Cap | $62.42B | $112.24B |
Volume | 2,918,760 | 105,663,236 |
Sector | Financials | Health |
52-Week High | $41.56 | $105.35 |
52-Week Low | $28.37 | $73.75 |
Typical Hold Time | 80 Days | 63 Days |
Enterprise Value | $77.06B | $131.58B |
Dividend Yield | 3.46% | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deutsche Bank (DB) trades at $33.68, up 0.39% today, with a bearish technical signal from moving averages but recent earnings beats. The stock shows attractive valuation with a P/E of 9.09 and P/B of 0.71, while net income surged to $6.93B in 2025. News highlights include strategic appointments and a raised 2026 net interest income outlook, though Q3 investment banking revenue is expected to be flat to slightly down.
The outlook is mixed: strong fundamentals and cost-saving initiatives support growth toward 2028 targets, but bearish technicals and a high proportion of hold ratings suggest near-term caution. Key risks include volatile investment banking revenue and macroeconomic pressures, while institutional sentiment remains divided with 57.58% hold ratings.
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
